What we're about

This group is for academic researchers, clinicians and students and is open to the public to learn in a group environment about cutting edge research on psychedelic neuroscience and applications in psychiatry and other health science disciplines.

We will pair the subject matter with a 30-60 min overview of the material, followed by Q&A and a group discussion to learn together about this new frontier in neuroscience and medicine.

While most of the content will be fairly academic, we aim to have a space for anyone to participate in regardless of your education or experience level with psychedelics, as these topics impact more than just the academic/medical research community, but humanity at large.

Lastly, please don't come to these meetings seeking/selling drugs and please don't arrive on drugs or you will be asked to leave and banned from attending future events. This is both for the safety of everyone involved and for the productivity of the lectures and discussions.

Join us!

Upcoming events (1)

Psychedelic Therapy: When Will We Have Access?

Link visible for attendees

A lot of attention is being paid to psychedelic therapies for a variety of ailments, most notably for major mental health disorders such as depression, PTSD, addiction, and end-of-life anxiety. While the news is exciting and offering glimmers of hope on the horizon for those that are suffering; the question of when, where, and for whom these therapies will be available is uncertain, and many are left wondering when they will have access. Splashy headlines in the media might be pushing people to seek out this therapy as something that is currently available from their doctors, however psychedelic therapy is still considered experimental and therefore illegal, according to the government agencies that regulate them (e.g. FDA and DEA).

This talk will demystify the clinical research on psychedelics and provide some answers about when these therapies will be available in a clinic near you, including what is currently available to patients, clinicians, and interested research participants wanting to get in on the action prior to their legalization as medicines.

  • This event is online and open to the public.
  • Tickets are $10 and can be purchased on Eventbrite.
  • The Zoom link to join will be enabled and emailed to ticket holders from Eventbrite prior to the start of the event
  • Event is free for supporting members of the Psychedelic Society of Minnesota (how to become a supporting member) - we'll send out the discount code to our current supporting members, so check your inbox or email us at [masked] to get your 100% discount code to use upon checkout on the Eventbrite ticket page. Limit 1 ticket per supporting member.
  • 100% of the proceeds from this event will go towards the Psychedelic Society of Minnesota’s psychedelic therapy fund to help offset costs for people who want to receive therapy but can’t afford it.

About the speaker:
Dr. Jessica Nielson is an Assistant Professor in the Departments of Psychiatry & Behavioral Sciences and Institute for Health Informatics at the University of Minnesota. She is Principal Investigator of the first psilocybin clinical trial in Minnesota, Founder and Executive Director of the Psychedelic Society of Minnesota, board member for the Minnesota Temple of Plant Medicine, and Innovation Alchemist at Big Psych.

THIS EVENT WILL BE RECORDED - if you are joining and prefer to stay anonymous for the recording, we encourage you to change your display name on Zoom and have your camera turned off.


Past events (21)

Becoming a Psychedelic Scientist

This event has passed

Photos (35)